Class II · Moderate risk Ongoing
Vitamin B-Complex
Reason Presence of a Foreign Substance; black particles observed in liquid
VirtPrex Prenatal/Postnatal Tablets
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
What was recalled
VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30
- Recalling firm
- Virtus Pharmaceuticals Opco II L
- NDC code
- 76439-348-30
- Origin
- TN, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0241-2017
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Folic recalls
See all
Class II · Moderate risk Completed
Folic Acid 1 mg/mL Hydroxocobalamin 1 mg/mL
Reason Lack of assurance of sterility.
Class II · Moderate risk Ongoing
Folic Acid 5mg/mL
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated
Folic Acid Tablets
Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk Terminated
Folic Acid 10mg/Ml Mdv Inj
Reason Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.